Share this video  

SABCS 2021 | What are you looking forward to at SABCS 2021?

Marta Vaz Batista • 30 Nov 2021
SABCS 2021
Breast Cancer
TUXEDO-1

Marta Vaz Batista, MD, Hospital Professor Doutor Fernando Fonseca, Amadora, Portugal, discusses what trials she is looking forward to at SABCS, focusing on the use of trastuzumab deruxtecan. This interview took place at the San Antonio Breast Cancer Symposium 2021 in San Antonio.

Disclosures

Advisory for AstraZeneca and Honoraria from Daiichi Sankyo

More from Marta Vaz Batista

2:26
Standard of care for patients with breast cancer who develop brain metastases
Marta Vaz Batista • 30 Nov 2021
4:15
DEBBRAH: T-DXd in HER2+ or HER2-low advanced breast cancer with CNS involvement
Marta Vaz Batista • 30 Nov 2021

Related Videos

1:01
Highlights in breast and gynecological cancer at ESTRO 2022
Pedro Lara • 17 May 2022
1:52
What impact will biosimilars have on clinical life?
Diana Lüftner • 21 Sep 2017
1:22
Drug shortages around the world: why communication is key
Fatima Cardoso • 22 Sep 2017
2:13
HER-2 conversion: a phenomenon in trastuzumab resistance
Russell Petty • 5 Nov 2019
The content of VJOncology is intended for healthcare professionals